A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.

NACompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

October 31, 2018

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

Stenting of the Common and/or External Iliac Arteries

Balloon expandable stenting of iliac occlusive disease.

Trial Locations (27)

10065

Cornell University, New York

14203

Research Foundation SUNY Buffalo, Buffalo

15213

UPMC, Pittsburgh

17011

Holy Spirit Cardiovascular Institute, Camp Hill

20782

MedStar Health Research Institute, Washington D.C.

23507

Sentara Medical Group, Norfolk

29425

MUSC, Charleston

29615

Greenville Memorial Hospital, Greenville

32504

Coastal Vascular Institute, Pensacola

33136

University of Miami, Miami

33176

Baptist Cardiac and Vascular Institute, Miami

37403

University Surgical Associates, Chattanooga

37660

Wellmont Holston Valley Medical Center, Kingsport

40202

University of Louisville, Louisville

43214

Ohio Health, Columbus

50266

Iowa Methodist Medical Center, West Des Moines

55422

North Memorial Heart & Vascular Institute, Plymouth

55805

Essentia Institute for Rural Health / St Mary's Hospital, Duluth

58122

Sanford Clinic - Clinical Research, Fargo

60007

Cardiovascular Associates, Elk Grove Village

77030

The Methodist Hospital, Houston

85006

St. Luke's Medical Center, Phoenix

06518

Yale University School of Medicine, New Haven

07960

Advanced Vascular Associates, Morristown

07666

Holy Name Medical Center, Teaneck

02906

The Miriam Hospital, Providence

Unknown

Auckland City Hospital, Auckland

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT02080871 - A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries. | Biotech Hunter | Biotech Hunter